pindolol has been researched along with Infarct in 1 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Such infarction appears to give rise to a form of renovascular hypertension, the severity and sudden onset of which distinguishes it from renal fibrodysplasia, which is commonly observed in this age group." | 1.27 | Renal segmental infarction: a cause of reversible malignant hypertension. ( Corvol, P; Elkik, F; Idatte, JM; Ménard, J, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elkik, F | 1 |
| Corvol, P | 1 |
| Idatte, JM | 1 |
| Ménard, J | 1 |
1 other study available for pindolol and Infarct
| Article | Year |
|---|---|
Renal segmental infarction: a cause of reversible malignant hypertension.
Topics: Adult; Captopril; Diagnosis, Differential; Fibromuscular Dysplasia; Humans; Hypertension, Malignant; | 1984 |